A Study of Anlotinib and AK105 Injection in Subjects With Gastrointestinal Tumors, Urinary System Tumors, Neuroendocrine Tumors
Clinical trial NCT04207463 · UNKNOWN
Trial details
- NCT number
- NCT04207463
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-03
- Primary completion
- 2020-12-31
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.